USD 1.5b package aims to boost supply of new vaccine
Norway is one of six donors that have put money on the table for a mechanism designed to provide incentive to pharmaceutical companies to develop and supply vaccines to developing countries.
The Advance Market Commitment (AMC) is a USD 1.5 billion carrot to industry. The whole experiment rides on setting the “right" price. Too high, and AMC could end up as a giant subsidy to drug firms. Too low and companies might not take the bait.